Eli Lilly’s stock drops as it slashes the price of Zepbound: Time to buy the dip?

view original post

Eli Lilly’s decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and …